{"id":"https://openalex.org/W2007133271","doi":"https://doi.org/10.1007/s00210-008-0282-y","title":"The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity","display_name":"The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity","alternate_titles":[],"publication_year":2008,"publication_date":"2008-04-16","ids":{"openalex":"https://openalex.org/W2007133271","doi":"https://doi.org/10.1007/s00210-008-0282-y","mag":"2007133271","pmid":"https://pubmed.ncbi.nlm.nih.gov/18415081"},"language":"en","primary_location":{"id":"doi:10.1007/s00210-008-0282-y","doi":"https://doi.org/10.1007/s00210-008-0282-y","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00210-008-0282-y","pdf_url":null,"source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2007133271"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027330002","display_name":"Jacqueline A.M. Smith","orcid":"https://orcid.org/0000-0001-5028-8725","observed_orcids":["https://orcid.org/0000-0001-5028-8725"]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. A. M. Smith","raw_affiliation_strings":["Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA. jsmith@theravance.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA. jsmith@theravance.com","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066889736","display_name":"David T. Beattie","orcid":"https://orcid.org/0009-0004-8548-9980","observed_orcids":["https://orcid.org/0009-0004-8548-9980"]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. T. Beattie","raw_affiliation_strings":["Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062317656","display_name":"Daniel G. Marquess","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Marquess","raw_affiliation_strings":["Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109837375","display_name":"J P Shaw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J.-P. Shaw","raw_affiliation_strings":["Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109323973","display_name":"Ross G. Vickery","orcid":"https://orcid.org/0009-0000-7820-9961","observed_orcids":["https://orcid.org/0009-0000-7820-9961"]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. G. Vickery","raw_affiliation_strings":["Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110434114","display_name":"Patrick P.A. Humphrey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. P. A. Humphrey","raw_affiliation_strings":["Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance, Inc., 901 Gateway Boulevard, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4210133216"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5027330002"],"corresponding_institution_ids":["https://openalex.org/I4210133216"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":1.8494,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.84535727,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"378","issue":"1","first_page":"125","last_page":"137"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.7554000020027161,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.7554000020027161,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.22460000216960907,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht4-receptor-agonist","display_name":"5-HT4 receptor agonist","score":0.9570000171661377},{"id":"https://openalex.org/keywords/intrinsic-activity","display_name":"intrinsic activity","score":0.6489999890327454},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.6539999842643738},{"id":"https://openalex.org/keywords/camp","display_name":"cyclic AMP","score":0.6740000247955322},{"id":"https://openalex.org/keywords/esophageal-relaxation","display_name":"esophageal relaxation","score":0.9520000219345093},{"id":"https://openalex.org/keywords/colonic-contraction","display_name":"colonic contraction","score":0.8980000019073486},{"id":"https://openalex.org/keywords/tegaserod","display_name":"tegaserod","score":0.800000011920929},{"id":"https://openalex.org/keywords/mosapride","display_name":"mosapride","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cisapride","display_name":"cisapride","score":1.0},{"id":"https://openalex.org/keywords/gastrointestinal-motility-disorders","display_name":"gastrointestinal motility disorders","score":0.8429999947547913}],"concepts":[{"id":"https://openalex.org/C192096249","wikidata":"https://www.wikidata.org/wiki/Q18027442","display_name":"5-HT4 receptor","level":4,"score":0.8917373418807983},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7620699405670166},{"id":"https://openalex.org/C38533456","wikidata":"https://www.wikidata.org/wiki/Q1671589","display_name":"Intrinsic activity","level":4,"score":0.4564095437526703},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.4356663227081299},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4043370187282562},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.37724825739860535},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3365525007247925},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2918757200241089},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21764767169952393}],"mesh":[{"descriptor_ui":"D000242","descriptor_name":"Cyclic AMP","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003106","descriptor_name":"Colon","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003106","descriptor_name":"Colon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004947","descriptor_name":"Esophagus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004947","descriptor_name":"Esophagus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020117","descriptor_name":"Cisapride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D044422","descriptor_name":"Receptors, Serotonin, 5-HT4","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051638","descriptor_name":"Ether-A-Go-Go Potassium Channels","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053961","descriptor_name":"Azabicyclo Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D053961","descriptor_name":"Azabicyclo Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D058828","descriptor_name":"Serotonin 5-HT4 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00210-008-0282-y","doi":"https://doi.org/10.1007/s00210-008-0282-y","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00210-008-0282-y","pdf_url":null,"source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},{"id":"pmid:18415081","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18415081","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's archives of pharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":69,"referenced_works":["https://openalex.org/W56677962","https://openalex.org/W83715629","https://openalex.org/W609163373","https://openalex.org/W1662913097","https://openalex.org/W1822643200","https://openalex.org/W1897273837","https://openalex.org/W1906396765","https://openalex.org/W1929798050","https://openalex.org/W1951019233","https://openalex.org/W1967001791","https://openalex.org/W1969144895","https://openalex.org/W1975407849","https://openalex.org/W1975661708","https://openalex.org/W1977282936","https://openalex.org/W1991343266","https://openalex.org/W1991526552","https://openalex.org/W1997670741","https://openalex.org/W2000535235","https://openalex.org/W2004522200","https://openalex.org/W2008830399","https://openalex.org/W2014106658","https://openalex.org/W2017702415","https://openalex.org/W2020176970","https://openalex.org/W2021834168","https://openalex.org/W2023618163","https://openalex.org/W2030759164","https://openalex.org/W2030902457","https://openalex.org/W2031907840","https://openalex.org/W2032252653","https://openalex.org/W2033603525","https://openalex.org/W2036987718","https://openalex.org/W2038526909","https://openalex.org/W2043972017","https://openalex.org/W2044436224","https://openalex.org/W2046286465","https://openalex.org/W2047499026","https://openalex.org/W2058278066","https://openalex.org/W2071327709","https://openalex.org/W2071435998","https://openalex.org/W2072922834","https://openalex.org/W2074190081","https://openalex.org/W2074631079","https://openalex.org/W2078852369","https://openalex.org/W2081378538","https://openalex.org/W2093095026","https://openalex.org/W2093366809","https://openalex.org/W2093710588","https://openalex.org/W2094580786","https://openalex.org/W2094709583","https://openalex.org/W2095055104","https://openalex.org/W2104339472","https://openalex.org/W2105206759","https://openalex.org/W2106880509","https://openalex.org/W2131713441","https://openalex.org/W2137181647","https://openalex.org/W2137266207","https://openalex.org/W2145496597","https://openalex.org/W2147775891","https://openalex.org/W2159601487","https://openalex.org/W2160232350","https://openalex.org/W2163161835","https://openalex.org/W2163417352","https://openalex.org/W2167381827","https://openalex.org/W2169503005","https://openalex.org/W2264932050","https://openalex.org/W2418229780","https://openalex.org/W2424255308","https://openalex.org/W2473340042","https://openalex.org/W4235690972"],"related_works":["https://openalex.org/W2093366809","https://openalex.org/W2157825392","https://openalex.org/W1995856069","https://openalex.org/W2330940815","https://openalex.org/W2012837477","https://openalex.org/W7096275083","https://openalex.org/W2030902457","https://openalex.org/W1522676737","https://openalex.org/W2000535235","https://openalex.org/W1501397556"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2007133271","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
